Belgia - niemiecki - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eurogenerics afgekort "e.g." - spironolacton - tablette - 100 mg - spironolacton 100 mg - spironolactone

Austria - niemiecki - AGES (Agentur für Gesundheit und Ernährungssicherheit)

kwizda pharma gmbh - natriumalendronat trihydrat -

Unia Europejska - niemiecki - EMA (European Medicines Agency)

bayer ag - vericiguat - herzfehler - herz-therapie - treatment of symptomatic chronic heart failure.

Szwajcaria - niemiecki - Swissmedic (Swiss Agency for Therapeutic Products)

bayer (schweiz) ag - vericiguatum - filmtabletten - filmtablette: vericiguatum 2.50 mg, cellulosum microcristallinum, carmellosum natricum conexum, hypromellosum, lactosum monohydricum 61.20 mg, magnesii stearas, natrii laurilsulfas, Überzug: hypromellosum, talcum, e 171, pro compresso obducto corresp. natrium 0.80 mg. - herzinsuffizienz - synthetika

Szwajcaria - niemiecki - Swissmedic (Swiss Agency for Therapeutic Products)

bayer (schweiz) ag - vericiguatum - filmtabletten - filmtablette: vericiguatum 5.00 mg, cellulosum microcristallinum, carmellosum natricum conexum, hypromellosum, lactosum monohydricum 58.52 mg, magnesii stearas, natrii laurilsulfas, Überzug: e 172 (rubrum), hypromellosum, talcum, e 171, pro compresso obducto corresp. natrium 0.81 mg. - herzinsuffizienz - synthetika

Szwajcaria - niemiecki - Swissmedic (Swiss Agency for Therapeutic Products)

bayer (schweiz) ag - vericiguatum - filmtabletten - filmtablette: vericiguatum 10.00 mg, cellulosum microcristallinum, carmellosum natricum conexum, hypromellosum, lactosum monohydricum 117.00 mg, magnesii stearas, natrii laurilsulfas, Überzug: e 172 (flavum), hypromellosum, talcum, e 171, pro compresso obducto corresp. natrium 1.65 mg. - herzinsuffizienz - synthetika

Unia Europejska - niemiecki - EMA (European Medicines Agency)

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - drogen bei diabetes verwendet - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 und 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.

Niemcy - niemiecki - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

ratiopharm gmbh (3087881) - filmtablette - 10 mg

Niemcy - niemiecki - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

macleods pharma espana, s.l.u. (8176721) - filmtablette - 5 mg

Niemcy - niemiecki - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

macleods pharma espana, s.l.u. (8176721) - filmtablette - 10 mg